The pharma industry investments continued to grow in Finland last year

The results of our annual investment survey have been published.

24.03.2023 | Kaija Rinne, Senior Advisor, PharmaLex Finland

Crisis-tolerant security of medicine supply

Supply of medicines is one of the essential functions in society. The crises that we are now surrounded by were unforeseeable, but we can prepare for the disruptions that they might cause.  Preparedness means not only surviving the disruption, but also recovering quickly after the crisis. An accurate situational picture is the foundation of all preparedness.


Finland provides a good ecosystem for life science industry

We need to continue proving the ecosystem in order to stay competitiveness. Finland is a country with high-quality health and social care system, strong startup ecosystem and population with very positive attitude towards medical research. There is still hidden value to be captured.


Pharma Industry Finland – Government programme objectives for 2023

The economy and health go hand in hand.


PIF's new organisation as from 1 May 2022

Our association has started on 1 May with a new organization that has been built in line with our strategy.

1 2 3 4 5 6 7